Kay M Tomashek

Statistics

Publications

Citations

9.9K

H-Index

Active since

2020

Affiliations

National Institute of Allergy and Infectious Diseases(Current)

Emmes (United States)

Emory University

Baylor College of Medicine

The University of Texas at San Antonio Health Science Center

Kay M Tomashek is an author at National Institute of Allergy and Infectious Diseases specializing in placebo-controlled efficacy assessment, medicine, and pharmacotherapy.

Publications per year

2020–2024

Publications

Remdesivir for the Treatment of Covid-19 — Final Report

John H. Beigel, Kay M Tomashek, Lori E. Dodd et al. · New England Journal of Medicine · 2020 · 7.7K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

André C. Kalil, Thomas F. Patterson, Aneesh K. Mehta et al. · New England Journal of Medicine · 2020 · 1.9K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Cameron R. Wolfe, Kay M Tomashek, Thomas F. Patterson et al. · The Lancet Respiratory Medicine · 2022 · 128 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +3

Clinical Epidemiology and Outcomes of Pediatric Musculoskeletal Infections

Jumi Yi, James B. Wood, C. Buddy Creech et al. · The Journal of Pediatrics · 2021 · 49 citations · Full text

Medicine, Orthopedic Surgery, Pediatrics +14

Variability in the Management of Adults With Pulmonary Nontuberculous Mycobacterial Disease

Getahun Abate, Jack T. Stapleton, Nadine Rouphael et al. · Clinical Infectious Diseases · 2020 · 48 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +16

1–5 of 6